Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Anthropic Drops $6 Billion Decart AI Acquisition Talks
DOJ Launches Antitrust Investigation Into the NFL Over Broadcast Restrictions
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
U.S. Eases Iran Team Travel Restrictions Ahead of Seattle World Cup Match
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Asian Currencies Steady as Yen Holds Firm, Oil Tops $100
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Trump Signs Order to Cut Routine Childhood Vaccines
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Trump Plans New Executive Order to Address Rising NIL Costs in College Sports
FIFA Suspends Balogun Ban, Clears U.S. Striker for Belgium World Cup Clash
OpenAI Weighs AI Development Slowdown Over Safety Risks
Brazil Court Suspends Sigma Lithium Mine Operations
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit 



